DrugPatentWatch Database Preview
RHOPRESSA Drug Profile
When do Rhopressa patents expire, and what generic alternatives are available?
Rhopressa is a drug marketed by Aerie Pharms Inc and is included in one NDA. There are five patents protecting this drug.
This drug has thirty-four patent family members in seven countries.
The generic ingredient in RHOPRESSA is netarsudil dimesylate. One supplier is listed for this compound. Additional details are available on the netarsudil dimesylate profile page.
Summary for RHOPRESSA
| International Patents: | 34 |
| US Patents: | 5 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 3 |
| Patent Applications: | 8 |
| Drug Prices: | Drug price information for RHOPRESSA |
| DailyMed Link: | RHOPRESSA at DailyMed |
Generic Entry Opportunity Date for RHOPRESSA
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for RHOPRESSA
| (4-((1S)-1-(Aminomethyl)-2-(isoquinolin-6-ylamino)-2-oxoethyl)phenyl)methyl 2,4- dimethylbenzoate |
| [4-[(2S)-3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl]phenyl]methyl 2,4-dimethylbenzoate |
| 1254032-66-0 |
| 1628418-15-4 |
| AR-11324 |
| AR-11324 free base |
| AR11324 |
| Benzoic acid, 2,4-dimethyl-, (4-((1S)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl)phenyl)methyl ester |
| D11030 |
| ester 60 [PMID: 27072905] |
| GTPL9322 |
| Netarsudil |
| Netarsudil (USAN/INN) |
| Netarsudil [USAN:INN] |
| Netarsudil [USAN] |
| SCHEMBL16036278 |
| UNII-W6I5QDT7QI |
| W6I5QDT7QI |
| ZINC113149554 |
US Patents and Regulatory Information for RHOPRESSA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aerie Pharms Inc | RHOPRESSA | netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Aerie Pharms Inc | RHOPRESSA | netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Aerie Pharms Inc | RHOPRESSA | netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Aerie Pharms Inc | RHOPRESSA | netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Aerie Pharms Inc | RHOPRESSA | netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for RHOPRESSA
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Spain | 2553827 | ➤ Sign Up |
| Australia | 2014228790 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2010126626 | ➤ Sign Up |
| Canada | 2760611 | ➤ Sign Up |
| Japan | 2014208681 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
